Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Combined Application of Chimeric toxins and Saponin

06.09.2012
</a><strong>Background</strong><br>

Immunotoxins have to be administered in high doses due to low cytosolic uptake with the consequence of severe side effects. An improvement for immunotoxins was the development of a molecular adapter linking the toxic and targeting moiety. Due to cleavable endosomal and cytosolic peptides the adapter mediates cytosolic trapping of the toxin which leads to reduced side

effects on non-target dells in vitro. <br><br> <strong>Technology</strong><br> We offer a novel combination therapy that comprises the combined administration of individually non-toxic concentrations of a chimeric toxin and the triterpenoid saponin for an enhanced tumor cell-specific cytotoxic effect while non-target cells are not affected at the effective concentration. The combination therapy could be a new tool for the tumor therapy. Main characteristics are: Lower required doses of immunotoxin, High cytotoxity and high specifity, Reduction of undesired side effects. <br><br> <b>Benefits:</b><ul> <li>Tumor-specific targeting and extinction of tumor cells by chimeric toxins</li> <li>Reduction of undesired adverse effects of systemic applications</li> <li>Combination with saponins enhances rate of immunotoxin uptake and efficiency of chimeric toxin in target cells</li> <li>Combined application allows doses reduction of cytotoxic agent and minimize adverse effects without impairing efficacy</li> <li>Application in cell culture (ex vivo) and in mouse tumor model (in vivo) successfully tested </li></ul> <p><strong>IP Rights</strong><br> European Patent Applic. (07/2004) is granted soon<br> PCT application (07/2005)<br> Pending patent applications in Europe, Canada, USA and Japan <br><br> <strong>Patent Owner</strong><br> Charité - Universitätsmedizin Berlin<br> Freie Universität Berlin

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2831&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Microarray to determine responsiveness of tumors to antiangiogenic treatment
06.12.2016 | TechnologieAllianz e.V.

nachricht Peltier Adsorption Trap
29.11.2016 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>